"Working with Kureczka/Martin across three companies has proven to me the value of their input. Their industry expertise allows them to not only get up to speed quickly on critical issues but also to draw on prior experiences to provide grounded and salient advice, whether for a press release, Q&A responses, or key messages for investor meetings."

Gary C. Cupit, PharmD
CEO and Director
Somnus Therapeutics, Inc.

Who We Serve

Our clients are:

Life sciences companies: biopharmaceutical and specialty pharmaceutical, industrial biotech/cleantech, bioinformatics, diagnostics, and medical devices, and agbiotech

Emerging growth companies: start-ups, venture-funded, pre-IPO, newly public, emerging and established firms

Research institutions/governmental agencies with a focus on life sciences technology and issues, research and development

Companies seeking to build visibility and acceptance among key audiences, especially the media, corporate partners or acquirers and the financial community.

Among our current clients are public, private and governmental organizations around the world:

Public Companies

Halozyme, Nasdaq: HALO

Neurologix, OTCBB: NRGX

International Companies

Innate Therapeutics - New Zealand

Mesynthes - New Zealand

Private Companies

Eureka Genomics

The Gibson Network

Helsinn Therapeutics (US) Inc.

KaloBios Pharmaceuticals